We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

More Evidence Of Anemia Drug Risk: FDA

Law360 (January 4, 2008, 12:00 AM EST) -- Two new studies being examined by the U.S. Food and Drug Administration again indicate the risks of three anemia drugs, particularly when used by patients battling certain types of cancers with chemotherapy.

According to the federal agency, the two studies show that patients with breast cancer or advanced cervical cancer who take erythropoiesis-stimulating agents, or ESAs, to fight anemia caused by their chemotherapy died sooner or had more rapid tumor growth than similar patients who were not taking the anemia medication.

The studies come on the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.